Madaus joins Quanterix as CEO

Monday, September 19, 2011 01:06 PM

Quanterix has named Martin D. Madaus, Ph.D. chief executive officer. Madaus, who also retains his position as chairman, brings more than 20 years of experience in the diagnostics and life science industries, most recently serving as president, chairman and CEO of Millipore, acquired by Merck

"Quanterix recently announced partnerships to develop and manufacture a fully-automated instrument and 'smart consumables' for use in both the life sciences research and diagnostics markets.  Martin brings significant financial and commercial expertise that will be invaluable as the company executes its plan to launch the SiMoA platform, and we are thrilled to have Martin on board," said David Walt, Ph.D., scientific founder of Quanterix.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs